Clinical Trial Update: Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated FluGlucoScan (18F-fluorodeoxyglucose) for cancer imaging in patients with cancer or suspected cancer; the study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Colorectal Cancer
• Lung Cancer
• Lymphoma
• Thyroid Cancer

Drugs mentioned

• FluGlucoScan (fluorodeoxyglucose)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Brain Neoplasms, Lung Neoplasms | Phase 2, Phase 3 | Status: COMPLETED